Esophageal String Test Monitoring to Monitor Eosinophilic Esophagitis During Oral Immunotherapy
Part of paid clinical trials in Philadelphia, Pennsylvania.
- Sponsor
- Children's Hospital of Philadelphia
- Study ID
- NCT06389994
- Status
- Recruiting
Conditions
- Eosinophilic Esophagitis (EoE)
Eligibility Criteria
- Sex
- ALL
- Age
- 7 Years - 17 Years
- Healthy Volunteers
- Not accepted
Interventions
- Esophageal String Test — DEVICEThe EnteroTracker® capsule is supplied in pouches, each pouch containing a single capsule. The device is comprised of an ingestible capsule that contains a weighted ball and a highly absorbent nylon string. The looped portion of the string is secured externally to the patient's cheek and the rest of the capsule is swallowed by the patient.
Study Details
Patients with IgE mediated food Allergy have elevated risk of eosinophilic esophagitis, and new therapies like oral immunotherapy (OIT) carry additional risk of Eosinophilic Esophagitis (EoE). The goal of this study is to investigate the Esophageal String Test (EST) as a screening tool for Eosinophilic Esophagitis (EoE) during OIT therapy. Investigators will compare the efficacy of the Esophageal String Test to symptom assessment using a validated patient reported symptom questionnaire, the Pediatric Eosinophilic Esophagitis Symptom Score (PEESS) v2.0. Investigators will utilize these tools to screen patients at their baseline visit prior to the start of OIT, then at the 3- and 6-month OIT follow-up visits.
Key Dates
- Start date
- Apr 1, 2024
- Status verified
- May 2025
- Primary completion
- Apr 2, 2026
- Completion
- Oct 1, 2026
Study Design
- Enrollment
- 75 participants (estimated)
Arms
- Arm: Patients undergoing oral immunotherapyAll patients will have esophageal string test
Primary Outcome Measure
Esophageal String Test [ Time Frame: baseline, 3 month and 6 months ]
Central Contacts
- Sharon A Carbonara, MS, BSN, RN267.426.8603
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| The Children's Hospital of Philadelphia | Philadelphia | Pennsylvania | 19104 |
Find similar trials in Philadelphia, PA
Related Studies
- A U.S. Registry of Eosinophilic Esophagitis Pediatric, Adolescent and Adult Patients Treated With DUPIXENT® As Standard of CareRecruiting · Regeneron Pharmaceuticals · Phoenix, Arizona
- A Study of Dupilumab in Small Children With an Allergic Condition of the Esophagus (Food Pipe): Eosinophilic EsophagitisPHASE3 · Recruiting · Regeneron Pharmaceuticals · Phoenix, Arizona
- Effect of Dupilumab on the Muscle Function of the Esophagus (food Pipe) in Participants with Eosinophilic Esophagitis (EoE)PHASE4 · Recruiting · University of California, San Diego · La Jolla, California
- Surface EMG Testing on Swallowing in EoE PatientsRecruiting · Mayo Clinic · Rochester, Minnesota